Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer’s disease

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

(2014) Christiane Reitz et al.   BIOCHEMICAL PHARMACOLOGY

Plasma phospholipids identify antecedent memory impairment in older adults

(2014) Mark Mapstone et al.   NATURE MEDICINE

Dyslipidemia and the Risk of Alzheimer’s Disease

(2013) Christiane Reitz   Current Atherosclerosis Reports

Acat1 Knockdown Gene Therapy Decreases Amyloid-β in a Mouse Model of Alzheimer's Disease

(2013) Stephanie R Murphy et al.   MOLECULAR THERAPY

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

(2013) Jean-Charles Lambert et al.   NATURE GENETICS

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease

(2013) Luke Whiley et al.   NEUROBIOLOGY OF AGING

In-Vial Dual Extraction for Direct LC-MS Analysis of Plasma for Comprehensive and Highly Reproducible Metabolic Fingerprinting.

(2012) Luke Whiley et al.   ANALYTICAL CHEMISTRY

Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains

(2011) Leila Hejazi et al.   BIOCHEMICAL JOURNAL

Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease

(2011) Robin B. Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology

(2011) Yoshiaki Sato et al.   JOURNAL OF LIPID RESEARCH

Human metabolic individuality in biomedical and pharmaceutical research

(2011) Karsten Suhre et al.   NATURE

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

(2011) Paul Hollingworth et al.   NATURE GENETICS

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

(2011) Xianlin Han et al.   PLoS One

Elevated Stearoyl-CoA Desaturase in Brains of Patients with Alzheimer's Disease

(2011) Giuseppe Astarita et al.   PLoS One

Cholesteryl ester transfer protein inhibition to reduce cardiovascular risk: where are we now?

(2011) Philip Barter et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Current strategies in the discovery of small-molecule biomarkers for Alzheimer’s disease

(2011) Luke Whiley et al.   Bioanalysis

Metabolome in progression to Alzheimer's disease

(2011) M Orešič et al.   Translational Psychiatry

Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting

(2010) Karsten Suhre et al.   PLoS One

ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD

(2010) E. Y. Bryleva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fatty acid composition of cholesteryl esters of human meibomian gland secretions

(2010) Igor A. Butovich   STEROIDS

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

(2009) Nicola Greenberg et al.   ELECTROPHORESIS

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

(2009) Jean-Charles Lambert et al.   NATURE GENETICS

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

(2009) Denise Harold et al.   NATURE GENETICS

Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics

(2008) Ignasi Barba et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE